GeneTether Therapeutics, Inc. (TSE:GTTX)
CNQX:GTTX
Canadian Market
Holding TSE:GTTX?
Track your performance easily

GeneTether Therapeutics, Inc. (GTTX) Financial Statements

3 Followers

GeneTether Therapeutics, Inc. Financial Overview

GeneTether Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is C$-0.02; its P/E ratio is -0.97; GeneTether Therapeutics, Inc. is scheduled to report earnings on November 22, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -107.79K$ -144.22K$ -316.22K$ -27.58K$ -139.23K
EBITDA$ -107.79K$ -144.22K$ -316.22K$ -27.58K$ -139.23K
Net Income Common Stockholders$ -107.79K$ -144.22K$ -316.22K$ -27.58K$ -139.23K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.03M$ 1.25M$ 1.36M$ 1.36M$ 1.43M
Total Assets$ 1.10M$ 1.25M$ 1.41M$ 1.45M$ 1.57M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.03M$ -1.25M$ -1.36M$ -1.36M$ -1.43M
Total Liabilities$ 23.23K$ 54.86K$ 38.59K$ 30.33K$ 38.65K
Stockholders Equity$ 1.08M$ 1.20M$ 1.37M$ 1.42M$ 1.54M
Cash Flow-
Free Cash Flow$ -209.31K$ -78.67K$ -26.24K$ -42.11K$ -298.01K
Operating Cash Flow$ -209.31K$ -78.67K$ -26.24K$ -42.11K$ -298.01K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

GeneTether Therapeutics, Inc. Earnings and Revenue History

GeneTether Therapeutics, Inc. Debt to Assets

GeneTether Therapeutics, Inc. Cash Flow

GeneTether Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis